Impact of loss of skeletal muscle mass within 6-12 months after gastrectomy and S1 adjuvant chemotherapy on the survival prognosis of elderly patients with gastric cancer.
Shiro FujihataShinichi SakuramotoYosuke MorimotoKazuaki MatsuiKeiji NishibeppuGen EbaraShohei FujitaShuichiro OyaHirofumi SugitaSeigi LeeYutaka MiyawakiHiroshi SatoShuji TakiguchiKeishi YamashitaPublished in: Surgery today (2022)
It is necessary to prevent decline in the PMI of elderly patients from 6 months after gastrectomy and to administer adjuvant chemotherapy with about two-thirds or more RDI of S1 to improve their survival prognosis.